We found that IL-12A expression was higher in tumor tissues of mice receiving PD-1/PD-L1 antibodies than in baseline data (Fig. 7A) and that the tight junction and NSCLC pathway were also activated in non-responders. This evidence concerns the gene IL12A and neoplasm.